Kewaunee Scientific Corporation (KEQU) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jul 31 2026 to Jul 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kewaunee Scientific Corporation  (NASDAQ: KEQU)


Kewaunee Scientific's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kewaunee Scientific's ROI in the first quarter of 2026?
Kewaunee Scientific Corporation achieved a return on average invested assets (ROI) of 6.79 % in its first quarter of 2026, this is above KEQU's average return on investment of 4.96%.
Kewaunee Scientific Corporation invested over the 12 months ending in its first quarter of 2026 $135 million

ROI decreased relative to the period ending Apr 30 2026, due to the decline in net income.

Within the Healthcare sector 129 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 1187 to 1244.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jul 31 2026)
I. Quarter		 (Apr 30 2026)
IV. Quarter		 (Jan 31 2026)
III. Quarter		 (Oct 31 2025)
II. Quarter		 (Jul 31 2025)
I. Quarter
Y / Y Investment Change TTM 12.83 % 28.19 % 48.9 % 42.31 % 35.54 %
Y / Y Net Income Change TTM -26.83 % -9.65 % 76.61 % 128.95 % 458.71 %
Investment (TTM) in Millions 131 122 143 143 143
Return On Investment (TTM) 6.79 % 7.6 % 8.23 % 9.2 % 10.48 %
KEQU's Overall Ranking # 1244 # 1187 # 1037 # 882 # 734
Seq. Investment Change TTM -2.22 % -3.35 % 9.05 % 9.48 % 11.09 %
Seq. Net Income Change TTM -12.58 % -10.71 % -2.55 % -3.81 % 7.95 %
Net Income (TTM) in Millions 9 10 12 12 13

KEQU Company Profile >> Back to KEQU Roi Comparisons >> See Annual KEQU Return On Investment



Return On Investment KEQU's Ranking
Within: No.
Industry # 4
Sector # 130
Overall # 1244

Return On Investment Statistics
High Average Low
21.1 %
4.96 %
-15.14 %
(Apr 30 2024)   (Jan 31 2022)







Financial Statements
Kewaunee Scientific's I. Quarter Investments $ 131 Millions KEQU's Balance sheet
Kewaunee Scientific's I. Quarter Income $ 2 Millions Quarterly KEQU's Income Statement
KEQU's Income by Division See KEQU's Income by Division


KEQU Annual Return On Investment (Apr 30 2026)
2026		 (Apr 30 2025)
2025		 (Apr 30 2024)
2024		 (Apr 30 2023)
2023		 (Apr 30 2022)
2022
Total Investments in Millions 132 143 95 80 77
Y / Y Investment Growth -7.48 % 49.56 % 19.41 % 3.84 % 38.81 %
Net Income in Millions 10 12 19 1 -6
Y / Y Net Income Growth -9.65 % -39.22 % 1302.28 % - -
Annual Return On Investment 7.92 % 8.12 % 19.97 % 1.7 % -7.8 %


Annual Roi Comment
In the fiscal year 2026 ROI decreased relative to the previous year to 7.92 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KEQU's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KEQU's Competitors
Subscribers only: Roi for Kewaunee Scientific's Suppliers
Subscribers only: Return On Investment for KEQU's Customers

Other Ratios
KEQU's Roa KEQU's Inventory Turnover Ratio KEQU's Growth Rates KEQU's Dividend Statistics
KEQU's Profitability Ratios KEQU's Asset Turnover Ratio KEQU's Dividend Growth
KEQU's Roe KEQU's Valuation Ratios KEQU's Financial Strength Ratios KEQU's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 31 2026, within Healthcare Sector ROI
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %

Date modified: 2026-09-12T18:36:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.